AG真人官方

STOCK TITAN
  1. Home
  2. Sec-filings
  3. OHI
  4. [Form 4] Omega Healthcare Investors Inc. Insider Trading Activity

[Form 4] Omega Healthcare Investors Inc. Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

Insider sale by a director: The Form 4 shows that director Lisa Egbuonu-Davis reported two open-market sales of Omega Healthcare Investors (OHI) common stock on 08/08/2025: 200 shares at $40.16 and 2,300 shares at $40.157318,654 shares beneficially owned.

Vendita insider da parte di una direttrice: Il Form 4 indica che la direttrice Lisa Egbuonu-Davis ha segnalato due vendite sul mercato aperto delle azioni ordinarie di Omega Healthcare Investors (OHI) il 08/08/2025: 200 shares at $40.16 e 2,300 shares at $40.1573. Dopo le operazioni riportate, il deposito mostra la detenzione beneficiaria di 18,654 shares.

Venta de insider por una directora: El Form 4 muestra que la directora Lisa Egbuonu-Davis inform贸 dos ventas en el mercado abierto de acciones ordinarias de Omega Healthcare Investors (OHI) el 08/08/2025: 200 shares at $40.16 y 2,300 shares at $40.1573. Tras las operaciones comunicadas, la presentaci贸n indica la propiedad beneficiaria de 18,654 shares.

鞛勳洂(鞚挫偓)鞚� 雮措秬鞛� 毵る弰: Form 4鞐愲姅 鞚挫偓 Lisa Egbuonu-Davis臧� 2025-08-08鞐� Omega Healthcare Investors(OHI) 氤错喌欤茧ゼ 瓿店皽 鞁滌灔鞐愳劀 霊� 彀 毵る弰頃� 瓴冹溂搿� 氤搓碃霅� 雮挫毄鞚� 響滌嫓霅橃柎 鞛堨姷雼堧嫟: 200 shares at $40.16 氚� 2,300 shares at $40.1573. 氤搓碃霅� 瓯半灅 鞚错泟 鞝滌稖靹滌棎電� 18,654 shares毳� 鞁れ鞝侅溂搿� 氤挫湢頃橁碃 鞛堧姅 瓴冹溂搿� 旮办灛霅橃柎 鞛堨姷雼堧嫟.

Vente d'initi茅 par une administratrice : Le formulaire 4 indique que l'administratrice Lisa Egbuonu-Davis a d茅clar茅 deux ventes sur le march茅 ouvert d'actions ordinaires d'Omega Healthcare Investors (OHI) le 08/08/2025 : 200 shares at $40.16 et 2,300 shares at $40.1573. Apr猫s les op茅rations signal茅es, le d茅p么t fait 茅tat de la d茅tention b茅n茅ficiaire de 18,654 shares.

Insider-Verkauf durch eine Direktorin: Das Form 4 zeigt, dass Direktorin Lisa Egbuonu-Davis am 08/08/2025 zwei Verk盲ufe von Omega Healthcare Investors (OHI) Stammaktien am offenen Markt meldete: 200 shares at $40.16 und 2,300 shares at $40.1573. Nach den gemeldeten Transaktionen weist die Einreichung 18,654 shares als wirtschaftlich gehalten aus.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Director disclosed routine sales totaling 2,500 OHI shares at roughly $40 each, reducing reported beneficial ownership to 18,654 shares.

The reported transactions are straightforward open-market dispositions by a company director. The Form 4 lists two sales on the same transaction date at very similar prices, suggesting execution around the same trading window. There is no accompanying information about any Rule 10b5-1 plan or other pre-arranged plan in the filing text provided. From a governance perspective, such filings are standard disclosures required for transparency but do not on their face indicate governance concerns.

TL;DR: Insider sold 200 and 2,300 OHI shares at about $40.16; the trades disclose nothing about company fundamentals or material corporate events.

For investors, these transactions signal insider liquidity rather than new information about the business. The prices reported ($40.16 and $40.1573) provide specific execution levels; the filing does not disclose intent or use of proceeds. Absent further context鈥攕uch as size relative to total insider holdings or linkage to a trading plan鈥攖hese sales are neutral from a market-impact standpoint.

Vendita insider da parte di una direttrice: Il Form 4 indica che la direttrice Lisa Egbuonu-Davis ha segnalato due vendite sul mercato aperto delle azioni ordinarie di Omega Healthcare Investors (OHI) il 08/08/2025: 200 shares at $40.16 e 2,300 shares at $40.1573. Dopo le operazioni riportate, il deposito mostra la detenzione beneficiaria di 18,654 shares.

Venta de insider por una directora: El Form 4 muestra que la directora Lisa Egbuonu-Davis inform贸 dos ventas en el mercado abierto de acciones ordinarias de Omega Healthcare Investors (OHI) el 08/08/2025: 200 shares at $40.16 y 2,300 shares at $40.1573. Tras las operaciones comunicadas, la presentaci贸n indica la propiedad beneficiaria de 18,654 shares.

鞛勳洂(鞚挫偓)鞚� 雮措秬鞛� 毵る弰: Form 4鞐愲姅 鞚挫偓 Lisa Egbuonu-Davis臧� 2025-08-08鞐� Omega Healthcare Investors(OHI) 氤错喌欤茧ゼ 瓿店皽 鞁滌灔鞐愳劀 霊� 彀 毵る弰頃� 瓴冹溂搿� 氤搓碃霅� 雮挫毄鞚� 響滌嫓霅橃柎 鞛堨姷雼堧嫟: 200 shares at $40.16 氚� 2,300 shares at $40.1573. 氤搓碃霅� 瓯半灅 鞚错泟 鞝滌稖靹滌棎電� 18,654 shares毳� 鞁れ鞝侅溂搿� 氤挫湢頃橁碃 鞛堧姅 瓴冹溂搿� 旮办灛霅橃柎 鞛堨姷雼堧嫟.

Vente d'initi茅 par une administratrice : Le formulaire 4 indique que l'administratrice Lisa Egbuonu-Davis a d茅clar茅 deux ventes sur le march茅 ouvert d'actions ordinaires d'Omega Healthcare Investors (OHI) le 08/08/2025 : 200 shares at $40.16 et 2,300 shares at $40.1573. Apr猫s les op茅rations signal茅es, le d茅p么t fait 茅tat de la d茅tention b茅n茅ficiaire de 18,654 shares.

Insider-Verkauf durch eine Direktorin: Das Form 4 zeigt, dass Direktorin Lisa Egbuonu-Davis am 08/08/2025 zwei Verk盲ufe von Omega Healthcare Investors (OHI) Stammaktien am offenen Markt meldete: 200 shares at $40.16 und 2,300 shares at $40.1573. Nach den gemeldeten Transaktionen weist die Einreichung 18,654 shares als wirtschaftlich gehalten aus.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Egbuonu-Davis Lisa
(Last) (First) (Middle)
303 INTERNATIONAL CIRCLE
SUITE 200
(Street)
HUNT VALLEY MD 21030
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
OMEGA HEALTHCARE INVESTORS INC [ OHI ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
08/08/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/08/2025 S 200 D $40.16 20,954 D
Common Stock 08/08/2025 S 2,300 D $40.1573 18,654 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
/s/ Meghan C. Lyons, Attorney-in-Fact 08/11/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source:

FAQ

What insider activity did OHI report in this Form 4?

Director Lisa Egbuonu-Davis reported two sales on 08/08/2025: 200 shares at $40.16 and 2,300 shares at $40.1573

How many OHI shares does the reporting person own after the transactions?

The filing shows the reporting person beneficially owned 18,654 shares following the reported transactions.

Were the reported transactions purchases or sales for OHI insider activity?

Both reported transactions are sales (transaction code S) of common stock.

Do the Form 4 disclosures mention a trading plan (Rule 10b5-1)?

The text provided does not include any statement that these sales were made pursuant to a Rule 10b5-1 plan.

Who signed the Form 4 filing for the reporting person?

The filing was signed by an attorney-in-fact, Meghan C. Lyons, on behalf of the reporting person.
Stock OHI logo
Omega Healthcare

NYSE:OHI

OHI Rankings

#801 Ranked by Market Cap
#492 Ranked by Dividends

OHI Latest News

OHI Latest SEC Filings

OHI Stock Data

11.86B
294.37M
0.21%
72.19%
3.3%
REIT - Healthcare Facilities
AG真人官方 Estate Investment Trusts
United States
HUNT VALLEY